Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind Placebo-Controlled Study of Buprenorphine Transdermal System (BTDS) in Patients With Osteoarthritis of the Hip or Knee

NCT00314652 is registered in ClinicalTrials.gov with Purdue Pharma LP as lead sponsor.

NCT NCT00314652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00314652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind Placebo-Controlled Study of Buprenorphine Transdermal System (BTDS) in Patients With Osteoarthritis of the Hip or Knee
Lead sponsor
Purdue Pharma LP
Phase
Phase 3
Overall status
Completed
Start date
June 30, 1999
Completion date
October 31, 1999
Enrollment
260
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis